Pivotal and Long-term Efficacy and Safety of ZEPOSIA in Relapsing Multiple Sclerosis: An Expert Video Series

Disease State

Introduction to ZEPOSIA
and Study Designs

Clinical Efficacy with

BVL and SDMT Data

Safety and Tolerability

Dosing and Initiation

Summary and Important
Safety Information



This video is intended only for healthcare professionals in the US and is intended to be viewed as it was originally produced by Bristol Myers Squibb (BMS). The information provided is for educational purposes only. The contents of this video are intended to be viewed in their entirety.

This promotional video is being sponsored by BMS. The speaker is not an employee of BMS, but is being paid to present on its behalf.
The content of this video is consistent with the FDA-approved full Prescribing Information for any referenced BMS products.

This website is best viewed
using the horizontal display on
your tablet device.

This website is best viewed
using the vertical display on
your mobile device.